Our goal is always to increase research capacity, research expertise and deliver clear patient benefits.
We work in partnership with a range of organisations; public, private and not-for-profit sectors, UK statutory funding institutes and other medical research charities who all share an interest in our strategic themes:
- Preventing kidney diseases
- Controlling and delaying kidney diseases
- Replacing, restoring and regenerating kidney function
- Pregnancy and kidney diseases
- Childhood kidney diseases
- Addressing inequality in kidney diseases
- Rare kidney diseases.
Our flexible approach allows us to work across a wide range of UK and international partners. We have a variety of business models, from co-funding large scale research projects to offering support for the very best early-stage renal research careers.
Why partner with us?
- We have decades of experience working with the UK’s top scientists and clinicians
- We work in partnership with several commercial organisations
- We are members of the ABPI patient and public involvement group and we adhere to the ABPI code of practice
- We are members of the Association of Medical Research Charities (AMRC), Scottish Medicines Consortium (SMC) Patient Group Partners and a member of the SMC Public Involvement Network and the All Wales Medicines Strategy Group's Patient and Public Involvement Group
- We have robust governance processes for all our research.
What we offer our partners
- An excellent track record in partnerships
- Best practice approach to funding research
- Access to an extensive network of renal research innovators, academic experts and institutions
- Delivering patient views and expertise.
Title Description Kidney Beam, the platform helping kidney patients’ wellbeing through live, online and on demand exercise classes and programmes, is being bolstered by support across the kidney community. In an unprecedented move, Kidney Research UK is joining forces with Kidney Care UK, the National Kidney Federation and the UK Kidney Association, to provide financial…
Kidney Research UK has been chosen to be the BioIndustry Association‘s charity partner for 2022. The partnership aims to raise funds, increase awareness of kidney health, and promote kidney research to the life sciences ecosystem. The BIA, the UK’s trade association for innovative life sciences, will support Kidney Research UK both through employee fundraising activities and strategic opportunities across the next 12 months. The partnership…
At Kidney Research UK we are determined to make research happen faster and make it count for patients sooner. Although we are the largest charity dedicated to funding kidney research in the UK, if we are going to end kidney disease, we need to do more to drive discoveries and make sure advances in research rapidly make a difference…
The main function of iron in the body is to form haemoglobin in red cells to carry oxygen to all the organs and tissues of the body. However, it is becoming increasingly apparent that iron has other important functions in the body, particularly in relation to how the heart and muscles function. A lack of…
The UK Renal Research Strategy recognised the need for a kidney biobank. Kidney Research UK has led the collaboration with industry and academia to launch NURTuRE (the National Unified Renal Translational Research Enterprise) – the first kidney biobank covering England, Scotland and Wales and a key resource for the renal research community. What will be…
ASSIST-CKD – identifying and monitoring people at greatest risk of progressive chronic kidney disease.
We are leading a UK-wide project, supported by the Health Foundation, which involves over 20 renal units and pathology laboratories, and their surrounding GP practices covering an estimated population of around 11-12 million people across the UK. The project is known as ASSIST-CKD. Our aim is to provide better and safer patient care by identifying…
Iron and Heart – a pilot clinical trial in iron deficient but non-anaemic people with advanced chronic kidney disease.
The Anaemia Clinical Study Group (CSG), sought to deliver a small pilot clinical trial to produce initial evidence on whether iron loading can reverse abnormality in heart muscle function and relieve symptoms associated with skeletal muscle impairment in chronic kidney disease (CKD) patients. This pilot clinical study is academically-led by Professor Sunil Bhandari at Hull…
A pioneering trial of worldwide importance We have co-ordinated a pioneering clinical trial investigating the optimum amount of intravenous iron that can be given to patients on dialysis to treat anaemia effectively and safely. A complication of being treated for kidney failure using haemodialysis is that patients develop anaemia and iron deficiency. This is a condition…
For more information or if you have any questions, get in touch with our Research Unit: